Events

Upcoming events in English:

 

 

Webinar |Tuesday April 29th 2025, 6PM UTC+3
Gül Dölen: Reopening critical periods with psychedelics (and why we gave octopuses MDMA)

 

Webinar |Thursday May 8th 2025, 6PM UTC+3

Victoria Litman: The Necessity of Regulating Psychedelic Spiritual Care

 

Webinar | Thursday May 22nd 2025, 6PM UTC+3
Helena Aicher: Psychedelic therapy – refining the claim of a paradigm shift

 

 

• • • • •
Webinar Mon April 7th 2025 Anna Becker: LSD for depression and the effects of SSRIs and ketanserin on psychedelics - At least in the popular culture of the 1950s and 1960s, LSD was almost synonymous with “psychedelic drugs”. In the current second major wave of psychedelic research, psilocybin has received much more attention than LSD. Two relevant reasons for this are the shorter effects of psilocybin and the negative stigma attached to LSD. But as… Read more
Webinar Tue Mar 18th 2025 Débora González: Therapeutic potential of ayahuasca in grief - Can ayahuasca be helpful for dealing with grief? This question will be explored in a webinar lecture organized by the Finnish Association for Psychedelic Research (Psykedeelitutkimusyhdistys) on Tue March 18, 2025, at 6PM UTC+2. Drawing from a clinical study with 82 participants, psychologist Débora González will share the principal outcomes of the study. We will… Read more
Webinar Thu Feb 27th 2025 Esenia Cassidy: Psychedelics and attachment – the fundamentals, implications, and new frontiers - Attachment theory investigates the role of early relationships in shaping an individual’s later emotional bonds and behaviour. What are its implications for the effects of psychedelics? In a webinar lecture organized by the Finnish Association for Psychedelic Research on Thursday Feb 27th, 6–8PM UTC+2, interdisciplinary researcher Esenia Cassidy will present a talk that delves into… Read more
Webinar Dec 9th, 2024 Max Wolff: What competencies should psychedelic therapists have and develop? - To practice psychedelic therapy safely and effectively, practitioners need a broad range of competences. Many of these overlap with what is needed from regular psychotherapy practices, but there are also psychedelic-specific areas. Psychologist and psychotherapist Max Wolff, who leads MIND Foundation’s Augmented Psychotherapy Training (APT) program, will present on the topic on Monday Dec 9th… Read more
Webinar Nov 18th, 2024 Balázs Szigeti: Is psychedelic citizen science the future? - One of the key challenges related to researching psychedelics is the high cost involved. One way to get around this challenge is by citizen science which involves the active participation of the public in the scientific process. Psychedelic science stands to benefit significantly from this approach due to the widespread use of these substances. Millions… Read more
Webinar Oct 7th, 2024. Jay Olson: Tripping on nothing – the hidden role of placebo effects in psychedelic drugs - Is it possible to have a psychedelic experience from a placebo? The past decade has seen a surge of interest in psychedelics across the world, but there are growing concerns about study methodology. One of those concerns relates to blinding: because participants generally know whether they have taken a psychedelic drug, maintaining experimental blinding is… Read more
Webinar April 29th, 2024: Jules Evans – Psychological harms and ethical mishaps in psychedelic culture and industry - Based on discussions of psychedelics in scientific journals and the media, you might get an impression that they are pretty much safe and almost risk-free, at least in clinical settings and for carefully screened participants. There are, however, estimates that perhaps 10 % of people who’ve taken psychedelics have experienced difficulties that last longer than… Read more
Webinar April 10th, 2024: Grant Jones – Naturalistic psychedelic use and health in communities of color - Psychedelics are gaining increased attention in both clinical research and popular culture as they represent novel treatments for a host of difficult-to-treat mental health conditions (e.g., PTSD, depression). Much of this interest has been driven by a number of groundbreaking clinical trials that have demonstrated the possible therapeutic efficacy of these substances in carefully controlled… Read more
Webinar March 6th, 2024: Alex Belser – EMBARK Psychedelic Therapy: a New Open-Source Model - The conventional history of psychedelic-assisted therapy (PAT) research has been criticized for things such as missing critical histories of harm and the stories of marginalized groups, and a lack of focus on key therapeutic elements such as therapist–participant relationship, attentiveness to the body, counseling for spiritual experiences, and ethical considerations. On Wednesday March 6th 2024… Read more
Webinar February 5th 2024: Rafael Moliner – How do psychedelics induce neuroplasticity and therapeutic effects? - Recent studies have shed light on the potential use of psychedelics such as LSD and psilocybin for depression. While known for their quick and lasting antidepressant effects, the hallucinogenic properties of these substances, with the risks inherent to them, may limit their widespread clinical adoption. Recent research indicates that some of their therapeutic benefits might… Read more